{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T10:42:00Z","timestamp":1786272120461,"version":"build-2736575974"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0952"],"award-info":[{"award-number":["2023A03J0952"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0953"],"award-info":[{"award-number":["2023A03J0953"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023C\u2010TS33"],"award-info":[{"award-number":["2023C\u2010TS33"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2026,2,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>\n                      Non\u2010alcoholic fatty liver disease (NAFLD), a chronic metabolic disorder characterized by ectopic lipid deposition in hepatocytes, currently lacks evidence\u2010based pharmacotherapies, rendering probiotic\u2010based strategies\u2014particularly those utilizing\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                      <\/jats:styled-content>\n                      (LR)\u2014a promising therapeutic avenue. Bacterial extracellular vesicles from\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                      <\/jats:styled-content>\n                      modulate NAFLD progression, but their molecular mechanisms remain unelucidated.\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                      <\/jats:styled-content>\n                      (LR\u2010BEVs) and\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Escherichia coli<\/jats:italic>\n                      <\/jats:styled-content>\n                      (E\u2010BEVs) were isolated via sequential ultracentrifugation, validated for morphology\/size by TEM and NTA, and their uptake into THLE\u20102 hepatocytes was traced with DIL fluorescent dye. In\u00a0vitro, oleic acid (OA)\u2010induced steatosis in THLE\u20102 cells was used to assess BEV effects via CCK\u20108, ALT\/AST\/TG, IL\u20101\u03b2\/IL\u20106, ROS, and Oil Red O. In\u00a0vivo, high\u2010fat diet\u2010induced murine NAFLD evaluated BEV therapeutic potential. Mechanistically, transcriptomics, Apelin receptor inhibition (ML221), and Western blotting explored the Apelin pathway in LR\u2010BEV\u2010mediated NAFLD regulation. LR\u2010BEVs (~110\u2009nm) were isolated and internalized by THLE\u20102 hepatocytes. At 100\u2009ng\/mL, LR\u2010BEVs significantly suppressed IL\u20101\u03b2 and IL\u20106 release in THLE\u20102 cells, contrasting with the pro\u2010inflammatory effects of E\u2010BEVs. In\u00a0vitro, LR\u2010BEVs ameliorated OA\u2010induced steatosis, reversing suppressed proliferation, elevated ALT\/AST levels, inflammatory cytokine secretion, ROS accumulation, and lipid droplet deposition. In a murine model of high\u2010fat diet\u2010induced hepatic steatosis, LR\u2010BEV administration markedly attenuated hepatic lipid accumulation and concomitantly reduced serum levels of ALT, AST, TC, and TG, along with ameliorating hepatic inflammation and oxidative stress. Transcriptomic analysis implicated Apelin signaling as a key pathway modulated by LR\u2010BEVs, with enrichment of target genes (APLNR, SERPINE1, EGR1, ACTA2). Functional validation demonstrated that LR\u2010BEVs exert their anti\u2010steatotic effects\u2014promoting proliferation and inhibiting lipid accumulation, ALT\/AST elevation, TC, and TG increase\u2014specifically via Apelin pathway activation, as evidenced by the abrogation of these benefits by the Apelin receptor antagonist ML221. ML221 also reversed LR\u2010BEV\u2010induced upregulation of key Apelin pathway targets. LR\u2010BEVs exert anti\u2010steatotic efficacy via the Apelin signaling pathway activation in\u00a0vitro and in\u00a0vivo. These findings establish LR\u2010BEVs as novel NAFLD therapeutics and highlight their translational potential for metabolic liver diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1096\/fj.202502796rr","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T19:51:56Z","timestamp":1771444316000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["<scp>\n                      <i>Lactobacillus rhamnosus<\/i>\n                    <\/scp>\n                    \u2010Derived Extracellular Vesicles Mitigate Nonalcoholic Fatty Liver Disease Progression Through Activation of the Apelin Signaling Pathway"],"prefix":"10.1096","volume":"40","author":[{"given":"Jiyou","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery Guangzhou First People's Hospital  Guangzhou Guangdong People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengcai","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Sun Yat\u2010Sen University  Guangzhou Guangdong People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery Guangzhou First People's Hospital  Guangzhou Guangdong People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5030-8666","authenticated-orcid":false,"given":"Minqiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery Guangzhou First People's Hospital  Guangzhou Guangdong People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.01.006"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01709-7"},{"key":"e_1_2_12_4_1","article-title":"Advancements in Pharmacological Treatment of NAFLD\/MASLD: A Focus on Metabolic and Liver\u2010Targeted Interventions","volume":"12","author":"Ciardullo S.","year":"2024","journal-title":"Gastroenterology Report"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.041"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.11.014"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330595"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.997018"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2116"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11112651"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010202"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000566"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9FO02905B"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2023.05.010"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.962216"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108443"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-024-01055-6"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12303"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309990"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320622"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2331460"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.03.107"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1029146"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.021"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022034520943187"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175353"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.820002"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00100.2020"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.08.003"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2016.3391"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2023.106345"},{"key":"e_1_2_12_32_1","first-page":"10","article-title":"Platelets\u2010Driven Monocyte Activation Promotes Hypoxic Thromboinflammation Through the HIF\u20101\u03b1\u2010NLRP3\u2010EGR\u20101 Axis","volume":"10","author":"Chanchal S.","year":"2025","journal-title":"Haematologica"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2281156"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020126"},{"key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.dld.2023.11.023","article-title":"Apelin and the Gut Microbiome: Potential Interaction in Human MASLD","volume":"56","author":"Effenberger M.","year":"2024","journal-title":"Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0353"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7437"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202502796RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.202502796RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202502796RR","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:41:18Z","timestamp":1773326478000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202502796RR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,28]]}},"alternative-id":["10.1096\/fj.202502796RR"],"URL":"https:\/\/doi.org\/10.1096\/fj.202502796rr","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"2025-08-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71581"}}